[Diagnosis and treatment of episcleritis and scleritis].

Tappeiner, Christoph; Walscheid, K; Heiligenhaus, A (2016). [Diagnosis and treatment of episcleritis and scleritis]. Der Ophthalmologe, 113(9), pp. 797-810. Springer 10.1007/s00347-016-0344-3

Full text not available from this repository. (Request a copy)

Episcleritis is a benign and self-limiting disease, often with a recurrent course, manifesting mainly in young adults. In less than a third of patients, an associated systemic disease can be found. In contrast, scleritis is observed mainly in patients between the 4th and 6th decade of life, may lead to severe ocular complications, and is often associated with a systemic rheumatological disease. Diffuse, nodular, and necrotizing forms of scleritis can be differentiated. Necrotizing and posterior scleritis have a higher risk of complications and worse visual outcome. In most cases, medical history and slit lamp examination allow differentiation of episcleritis and scleritis. Whereas episcleritis is treated mainly symptomatically with artificial tears, topical corticosteroids, and potentially with systemic nonsteroidal anti-inflammatory drugs, scleritis requires early and aggressive anti-inflammatory treatment in a stepwise approach.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Tappeiner, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1433-0423

Publisher:

Springer

Language:

German

Submitter:

Christoph Tappeiner

Date Deposited:

18 Apr 2019 14:03

Last Modified:

18 Apr 2019 14:03

Publisher DOI:

10.1007/s00347-016-0344-3

PubMed ID:

27550224

Uncontrolled Keywords:

Complications Diagnosis Prognosis Systemic disease Treatment

URI:

https://boris.unibe.ch/id/eprint/93127

Actions (login required)

Edit item Edit item
Provide Feedback